Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1986 1
1988 3
1989 4
1991 1
1992 5
1993 2
1994 3
1995 5
1996 1
1997 1
1998 7
1999 1
2000 6
2001 5
2002 1
2003 6
2004 2
2005 15
2006 7
2007 11
2008 20
2009 11
2010 9
2011 20
2012 23
2013 12
2014 22
2015 17
2016 12
2017 17
2018 16
2019 19
2020 16
2021 24
2022 22
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
A Monoclonal Antibody for Malaria Prevention.
Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, Gordon IJ, Plummer SH, Trofymenko O, Hu Z, Campos Chagas A, O'Connell S, Basappa M, Douek N, Narpala SR, Barry CR, Widge AT, Hicks R, Awan SF, Wu RL, Hickman S, Wycuff D, Stein JA, Case C, Evans BP, Carlton K, Gall JG, Vazquez S, Flach B, Chen GL, Francica JR, Flynn BJ, Kisalu NK, Capparelli EV, McDermott A, Mascola JR, Ledgerwood JE, Seder RA; VRC 612 Study Team. Gaudinski MR, et al. Among authors: capparelli ev. N Engl J Med. 2021 Aug 26;385(9):803-814. doi: 10.1056/NEJMoa2034031. Epub 2021 Aug 11. N Engl J Med. 2021. PMID: 34379916 Free PMC article. Clinical Trial.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
Wu RL, Idris AH, Berkowitz NM, Happe M, Gaudinski MR, Buettner C, Strom L, Awan SF, Holman LA, Mendoza F, Gordon IJ, Hu Z, Campos Chagas A, Wang LT, Da Silva Pereira L, Francica JR, Kisalu NK, Flynn BJ, Shi W, Kong WP, O'Connell S, Plummer SH, Beck A, McDermott A, Narpala SR, Serebryannyy L, Castro M, Silva R, Imam M, Pittman I, Hickman SP, McDougal AJ, Lukoskie AE, Murphy JR, Gall JG, Carlton K, Morgan P, Seo E, Stein JA, Vazquez S, Telscher S, Capparelli EV, Coates EE, Mascola JR, Ledgerwood JE, Dropulic LK, Seder RA; VRC 614 Study Team. Wu RL, et al. Among authors: capparelli ev. N Engl J Med. 2022 Aug 4;387(5):397-407. doi: 10.1056/NEJMoa2203067. N Engl J Med. 2022. PMID: 35921449 Free PMC article. Clinical Trial.
Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.
Eke AC, Wang J, Amin K, Shapiro DE, Stek A, Smith E, Chakhtoura N, Basar M, George K, Knapp KM, João EC, Rungruengthanakit K, Capparelli E, Burchett S, Mirochnick M, Best BM; P1026s Protocol Team. Eke AC, et al. Among authors: capparelli e. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02260-19. doi: 10.1128/AAC.02260-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015036 Free PMC article. Clinical Trial.
Innovative clinical trial design for pediatric therapeutics.
Laughon MM, Benjamin DK Jr, Capparelli EV, Kearns GL, Berezny K, Paul IM, Wade K, Barrett J, Smith PB, Cohen-Wolkowiez M. Laughon MM, et al. Among authors: capparelli ev. Expert Rev Clin Pharmacol. 2011 Sep;4(5):643-52. doi: 10.1586/ecp.11.43. Expert Rev Clin Pharmacol. 2011. PMID: 21980319 Free PMC article. Review.
Advancing the prevention and treatment of HIV in children: priorities for research and development.
Penazzato M, Townsend CL, Sam-Agudu NA, Ruel TD, Archary M, Bekker A, Cressey TR, Colbers A, Sugandhi N, Rojo P, Rakhmanina N, Watkins M, Frigati L, Mukui I, Hafiz A, Vicari M, Capparelli EV, Abrams EJ; PADO-HIV 5 participants. Penazzato M, et al. Among authors: capparelli ev. Lancet HIV. 2022 Sep;9(9):e658-e666. doi: 10.1016/S2352-3018(22)00101-1. Epub 2022 Jul 18. Lancet HIV. 2022. PMID: 35863362 Review.
Personalized therapeutics: HIV treatment in adolescents.
Rakhmanina NY, Capparelli EV, van den Anker JN. Rakhmanina NY, et al. Among authors: capparelli ev. Clin Pharmacol Ther. 2008 Dec;84(6):734-40. doi: 10.1038/clpt.2008.187. Epub 2008 Oct 1. Clin Pharmacol Ther. 2008. PMID: 18830226 Free PMC article. Review.
Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.
Tang BH, Zhang JY, Allegaert K, Hao GX, Yao BF, Leroux S, Thomson AH, Yu Z, Gao F, Zheng Y, Zhou Y, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Jacqz-Aigrain E, van den Anker J, Wu YE, Zhao W. Tang BH, et al. Among authors: capparelli ev. Clin Pharmacokinet. 2023 Aug;62(8):1105-1116. doi: 10.1007/s40262-023-01265-z. Epub 2023 Jun 10. Clin Pharmacokinet. 2023. PMID: 37300630
Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial.
Yang J, Jain S, Capparelli EV, Best BM, Son MB, Baker A, Newburger JW, Franco A, Printz BF, He F, Shimizu C, Hoshino S, Bainto E, Moreno E, Pancheri J, Burns JC, Tremoulet AH. Yang J, et al. Among authors: capparelli ev. J Pediatr. 2022 Apr;243:173-180.e8. doi: 10.1016/j.jpeds.2021.12.035. Epub 2021 Dec 23. J Pediatr. 2022. PMID: 34953816 Clinical Trial.
Flecainide.
Capparelli E. Capparelli E. Conn Med. 1986 Jun;50(6):403-5. Conn Med. 1986. PMID: 3743061 No abstract available.
331 results